Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 18/20 | 0.73 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.55 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.55 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.55 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.54 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3575508 | 0.92 | CHEK2 (0.62) | CHEK2 | |
| SCHEMBL5177967 | 0.81 | CHEK2 (1.00) | CHEK2 | |
| SCHEMBL5178523 | 0.80 | CHEK2 (0.52) | CHEK2SIRT2SIRT1SIRT3 | |
| SCHEMBL20982670 | 0.78 | CHEK2 (0.86) | CHEK2PKN1PKN2 | |
| SCHEMBL4165387 | 0.77 | SIRT2 (0.71) | CHEK2SIRT2SIRT1SIRT3 | |
| SCHEMBL1378452 | 0.76 | CHEK2 (0.84) | CHEK2 | |
| SCHEMBL1381010 | 0.76 | CHEK2 (1.00) | CHEK2 | |
| SCHEMBL5676245 | 0.75 | CHEK2 (1.00) | CHEK2 | |
| SCHEMBL3925642 | 0.74 | CHEK2 (0.85) | CHEK2 | |
| SCHEMBL18229718 | 0.74 | HDAC6 (0.87) | CHEK2SIRT2SIRT1SIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4726235-B2 | — | — | 2011-07-20 | — | — | JP | claimed |
| EP-1613313-A1 | 2-PHENYL-BENZIMIDAZOL AND 2-PHENYL-IMIDAZO-4,5!-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-01-11 | — | — | EP | claimed |
| WO-2004093873-A1 | 2-PHENYL-BENZIMIDAZOL AND 2-PHENYL-IMIDAZO-`4,5!-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER | JANSSEN PHARMACEUTICA, N.V. (BE) | 2004-11-04 | — | — | WO | claimed |